Embodiments relate to subterranean operations and, in some embodiments, to introduction of fluids comprising kiln dust into a wellbore through a bottom hole assembly.
Wells are generally drilled into the ground to recover natural deposits of hydrocarbons and other desirable materials trapped in geological formations in the Earth's crust. Wells may be drilled by rotating a drill bit which is located on a bottom hole assembly at a distal end of a drill string. In conventional drilling, a wellbore is drilled to a desired depth and then the wellbore is lined with a larger-diameter pipe, typically referred to as a casing. Prior to inserting the casing and cementing it in place, the drill string and drill bit are removed from the wellbore. After the casing has been cemented in place, drilling is continued. In some instances, a technique referred to as “casing drilling” is used in which a casing is used in place of a drilling string. Similar to a drill string, the drill bit is connected to a distal end of the casing, and the casing is used to transmit rotational and axial forces to the drill bit. When the wellbore has been drilled to a desired depth, the casing may be cemented in place. In some instances, cement compositions and associated spacer fluids used in the cementing operation are placed into the wellbore through the bottom hole assembly. Casing drilling enables the well to be drilled and cased without the delays associated with removal of the drill bit and drill string from the wellbore.
A number of different fluids may be used in drilling and casing the wellbore. For instance, a drilling fluid may be pumped down through the drill string (or casing), out through the drill bit, and returned to the surface in the annulus between the drill string and the wellbore wall. The drilling fluid can act to lubricate and cool the drill bit as well as carry drill cuttings back to the surface. Spacer fluids can also be used in these operations. For instance, a spacer fluid may be used to displace drilling fluids from the wellbore before introduction of another fluid, such as a cement composition. Cement compositions may be used to cement the casing in the wellbore. The cement composition may be allowed to set in the annulus between the casing and the wellbore wall, thereby forming an annular sheath of hardened cement (e.g., a cement sheath) that should support and position the pipe string in the wellbore and bond the exterior surface of the pipe string to the walls of the wellbore. While a variety of different fluids have been used with some success in drilling and casing wellbore, improved fluids and techniques for their placement are needed in subterranean operations.
These drawings illustrate certain aspects of some of the embodiments and should not be used to limit or define the invention.
Embodiments relate to subterranean operations and, in some embodiments, to introduction of a treatment fluid comprising kiln dust into a wellbore through a bottom hole assembly. In particular embodiments, the bottom hole assembly may be attached to a tubular, such as a drill pipe and/or a casing. By way of example, the treatment fluid may be used in a casing drilling operation, wherein the treatment fluid may be introduced into a wellbore through a bottom hole assembly that is attached to a distal end of a casing. In some embodiments, the treatment fluid may be introduced through a drill bit at a distal end of the bottom hole assembly. The term “treatment fluid” does not imply any particular action by the fluid or any component thereof. Treatment fluids may be used, for example, for drilling, completion, production, work over, or in any way to prepare a wellbore and/or well equipment for recovery of materials residing in a subterranean formation penetrated by the wellbore.
Referring now to
A pump 124 (e.g., a mud pump) may circulate the drilling fluid 126 through a feed pipe 128 and to the kelly 110, which conveys the drilling fluid 126 downhole through the interior of the casing 108 and through one or more orifices in the drill bit 116. The drilling fluid 126 may then be circulated back to the surface via an annulus 130 defined between the casing 108 and the walls of the wellbore 118. At the surface, the recirculated or spent drilling fluid 126 exits the annulus 130 and may be conveyed to one or more fluid processing unit(s) 132 via an interconnecting flow line 134. After passing through the fluid processing unit(s) 132, a “cleaned” drilling fluid 126 may be deposited into a nearby retention pit 136 (e.g., a mud pit). While illustrated as being arranged at the outlet of the wellbore 118 via the annulus 130, those skilled in the art will readily appreciate that the fluid processing unit(s) 132 may be arranged at any other location in the casing drilling system 100 to facilitate its proper function, without departing from the scope of the scope of the disclosure.
Referring now to
With reference now to
The spacer fluid 140 may be pumped down through the casing 108, out through the bottom hole assembly 114, and into the annulus 130. In some embodiments, the spacer fluid 140 may be introduced into the annulus 130 through the drill bit 116 on the bottom hole assembly 114. As illustrated, the spacer fluid 140 may also separate the drilling fluid 126 from a cement composition 142. The cement composition 142 may be introduced into the wellbore 118 behind the spacer fluid 140 to cement the casing 108 into the wellbore 118. The cement composition 142 may also be pumped down through the casing 108, out through the bottom hole assembly 114, and into the annulus 130. In some embodiments, the cement composition 142 may be a treatment fluid that comprises kiln dust and water. In some embodiments, both the spacer fluid 140 and the cement composition 142 may comprise kiln dust. In alternative embodiments, either the spacer fluid 140 or cement composition 142 may comprise kiln dust. In an additional embodiment, at least a portion of used and/or unused kiln dust containing spacer fluid 140 may be included in the cement composition 142 that is placed into the wellbore 118 and allowed to set. As will be described in more detail below the spacer fluid 140 and/or cement composition 142 comprising kiln dust may also comprise one or more additional additives in various concentrations and combinations.
Referring now to
Referring now to
The exemplary treatment fluids disclosed herein may directly or indirectly affect one or more components or pieces of equipment associated with the preparation, delivery, recapture, recycling, reuse, and/or disposal of the disclosed treatment fluids. For example, the disclosed treatment fluids may directly or indirectly affect one or more mixers, related mixing equipment, mud pits (e.g., retention pit 136, spacer retention pit 150), storage facilities or units, composition separators, heat exchangers, sensors, gauges, pumps, compressors, and the like used generate, store, monitor, regulate, and/or recondition the exemplary treatment fluids. The disclosed treatment fluids may also directly or indirectly affect any transport or delivery equipment used to convey the treatment fluids to a well site or downhole such as, for example, any transport vessels, conduits, pipelines, trucks, tubulars, and/or pipes used to compositionally move the treatment fluids from one location to another, any pumps, compressors, or motors (e.g., topside or downhole) used to drive the treatment fluids into motion, any valves or related joints used to regulate the pressure or flow rate of the treatment fluids, and any sensors (i.e., pressure and temperature), gauges, and/or combinations thereof, and the like. The disclosed treatment fluids may also directly or indirectly affect the various downhole equipment and tools that may come into contact with the treatment fluids such as, but not limited to, wellbore casing (e.g., casing 108), wellbore liner, completion string, insert strings, drill string, coiled tubing, slickline, wireline, drill pipe, drill collars, mud motors, downhole motors and/or pumps, cement pumps, surface-mounted motors and/or pumps, centralizers, turbolizers, scratchers, floats (e.g., shoes, collars, valves, etc.), logging tools and related telemetry equipment, actuators (e.g., electromechanical devices, hydromechanical devices, etc.), sliding sleeves, production sleeves, plugs, screens, filters, flow control devices (e.g., inflow control devices, autonomous inflow control devices, outflow control devices, etc.), couplings (e.g., electro-hydraulic wet connect, dry connect, inductive coupler, etc.), control lines (e.g., electrical, fiber optic, hydraulic, etc.), surveillance lines, drill bits (e.g., drill bit 116) and reamers, sensors or distributed sensors, downhole heat exchangers, valves and corresponding actuation devices, tool seals, packers, cement plugs, bridge plugs, and other wellbore isolation devices, or components, and the like.
Embodiments of the treatment fluids (e.g., spacer fluid 140, cement composition 142) may comprise kiln dust and water. In some embodiments, the treatment fluids may consolidate when left in a wellbore. For example, the treatment fluids may set and harden to gain compressive strength by reaction of the kiln dust in the water. In some embodiments, the treatment fluids may be foamed. For example, the foamed treatment fluids may comprise water, kiln dust, a foaming agent, and a gas. A foamed treatment fluid may be used, for example, where it is desired for the fluid to be lightweight and not exert excessive force on subterranean formations 120 penetrated by the wellbore 118. Embodiments of the treatment fluids may further comprise fly ash, barite, pumicite, a free water control additive, or a combination thereof. In accordance with present embodiments, the treatment fluid may be a spacer fluid 140 that displaces a first fluid (e.g., a drilling fluid 126) from the wellbore 118. In some embodiments, the spacer fluid 140 may have a higher yield point than the first fluid. In further embodiments, the treatment fluid may be a cement composition 142 that is used in cementing the casing 108 in the wellbore 118. Embodiment may further comprise using a treatment fluid comprising the kiln dust in drilling the wellbore 118. For example, the treatment fluid may be circulated past the drill bit 116 to carry drill cuttings back to the surface.
The treatment fluids generally should have a density suitable for a particular application as desired by those of ordinary skill in the art, with the benefit of this disclosure. In some embodiments, the treatment fluids may have a density in the range of from about 4 pounds per gallon (“ppg”) to about 24 ppg. In other embodiments, the treatment fluids may have a density in the range of about 4 ppg to about 17 ppg. In yet other embodiments, the treatment fluids may have a density in the range of about 8 ppg to about 13 ppg. Embodiments of the treatment fluids may be foamed or unfoamed or comprise other means to reduce their densities known in the art, such as lightweight additives. Those of ordinary skill in the art, with the benefit of this disclosure, should recognize the appropriate density for a particular application.
Kiln dust, as that term is used herein, refers to a solid material generated as a by-product of the heating of certain materials in kilns. The term “kiln dust” as used herein is intended to include kiln dust made as described herein and equivalent forms of kiln dust. Kiln dust typically exhibits cementitious properties in that it can set and harden in the presence of water. Examples of suitable kiln dusts include cement kiln dust, lime kiln dust, and combinations thereof. Cement kiln dust may be generated as a by-product of cement production that is removed from the gas stream and collected, for example, in a dust collector. Usually, large quantities of cement kiln dust are collected in the production of cement that are commonly disposed of as waste. Disposal of the cement kiln dust can add undesirable costs to the manufacture of the cement, as well as the environmental concerns associated with its disposal. The chemical analysis of the cement kiln dust from various cement manufactures varies depending on a number of factors, including the particular kiln feed, the efficiencies of the cement production operation, and the associated dust collection systems. Cement kin dust generally may comprise a variety of oxides, such as SiO2, Al2O3, Fe2O3, CaO, MgO, SO3, Na2O, and K2O. Problems may also be associated with the disposal of lime kiln dust, which may be generated as a by-product of the calcination of lime. The chemical analysis of lime kiln dust from various lime manufacturers varies depending on a number of factors, including the particular limestone or dolomitic limestone feed, the type of kiln, the mode of operation of the kiln, the efficiencies of the lime production operation, and the associated dust collection systems. Lime kiln dust generally may comprise varying amounts of free lime and free magnesium, lime stone, and/or dolomitic limestone and a variety of oxides, such as SiO2, Al2O3, Fe2O3, CaO, MgO, SO3, Na2O, and K2O, and other components, such as chlorides.
The kiln dust may be included in embodiments of the treatment fluids as a rheology modifier. Among other things, using the kiln dust in various embodiments can provide treatment fluids having rheology suitable for a particular application. Desirable rheology may be advantageous to provide a treatment fluid that is effective for drilling fluid displacement, for example, in spacer fluid embodiments. In some instances, the kiln dust can be used to provide a treatment fluid with a low degree of thermal thinning. For example, the treatment fluid may even have a yield point that increases at elevated temperatures, such as those encountered downhole.
The kiln dust may be included in the spacer fluids in an amount sufficient to provide, for example, the desired rheological properties. The concentration of kiln dust may also be selected to provide a low cost replacement for higher cost additives, such as Portland cement, that may typically be included in a particular treatment fluid. In some embodiments, the kiln dust may be present in a treatment fluid in an amount in the range of from about 1% to about 65% by weight of the treatment fluid (e.g., about 1%, about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, about 65%, etc.). In some embodiments, the kiln dust may be present in the treatment fluid in an amount in the range of from about 5% to about 60% by weight of the treatment fluid. In some embodiments, the kiln dust may be present in an amount in the range of from about 20% to about 35% by weight of the treatment fluid. Alternatively, the amount of kiln dust may be expressed by weight of cementitious components (“bwocc”). As used herein, the term “by weight of cementitious components” or “bwocc” refers to the amount of a component, such as kiln dust, relative to the overall amount of cementitious components used in preparation of the treatment fluid. Cementitious components include those components or combinations of components of the treatment fluid that set, or otherwise harden, to develop compressive strength, including, for example, kiln dust, hydraulic cement, fly ash, hydrated lime, and the like. For example, the kiln dust may be present in an amount in a range of from about 1% to 100% bwocc. (e.g., about 1%, about 5%, about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, 100%, etc.). In some embodiments, the kiln dust may be present in an amount in the range of from about 50% to 100% and, alternatively, from about 80% to 100% bwocc. One of ordinary skill in the art, with the benefit of this disclosure, should recognize the appropriate amount of kiln dust to include for a chosen application.
The water used in an embodiment of the treatment fluids may include, for example, freshwater, saltwater (e.g., water containing one or more salts dissolved therein), brine (e.g., saturated saltwater produced from a subterranean formations), seawater, or any combination thereof. Generally, the water may be from any source, provided that the water does not contain an excess of compounds that may undesirably affect other components in the treatment fluid. The water may be included in an amount sufficient to form a pumpable fluid. In some embodiments, the water may be included in the treatment fluids in an amount in a range of from about 40% to about 200% bwocc. In some embodiments, the water may be included in an amount in a range of from about 40% to about 150% bwocc.
Optionally, embodiments of the treatment fluids may further comprise fly ash. A variety of fly ashes may be suitable, including fly ash classified as Class C or Class F fly ash according to American Petroleum Institute, API Specification for Materials and Testing for Well Cements, API Specification 10, Fifth Ed., Jul. 1, 1990. Suitable examples of fly ash include, but are not limited to, POZMIX® A cement additive, commercially available from Halliburton Energy Services, Inc., Duncan, Okla. Where used, the fly ash generally may be included in the treatment fluids in an amount desired for a particular application. In some embodiments, the fly ash may be present in an amount in a range of from about 1% to about 99% bwocc (e.g., about 1%, about 5%, about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 99%, etc.). In some embodiments, the fly ash may be present in an amount in the range of from about 1% to about 20% and, alternatively, from about 1% to about 10% bwocc. One of ordinary skill in the art, with the benefit of this disclosure, should recognize the appropriate amount of the fly ash to include for a chosen application.
Optionally, embodiments of the treatment fluids may further comprise barite. In some embodiments, the barite may be sized barite. Sized barite generally refers to barite that has been separated, sieved, ground, or otherwise sized to produce barite having a desired particle size. For example, the barite may be sized to produce barite having a particle size less than about 200 microns in size. Where used, the barite generally may be included in the treatment fluids in an amount desired for a particular application. For example, the barite may be present in an amount in a range of from about 1% to about 99% bwocc (e.g., about 1%, about 5%, about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 99%, etc.). In some embodiments, the barite may be present in an amount in the range of from about 1% to about 20% and, alternatively, from about 1% to about 10% bwocc. One of ordinary skill in the art, with the benefit of this disclosure, should recognize the appropriate amount of the barite to include for a chosen application.
Optionally, embodiments of the treatment fluids may further comprise pumicite. Generally, pumicite is a volcanic rock that may exhibits cementitious properties, in that it may set and harden in the presence of hydrated lime and water. Hydrated lime may be used in combination with the pumicite, in some embodiments. Where used, the pumicite generally may be included in the treatment fluids in an amount desired for a particular application. For example, the pumicite may be present in an amount in a range of from about 1% to about 99% bwocc (e.g., about 1%, about 5%, about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 99%, etc.). In some embodiments, the pumicite may be present in an amount in the range of from about 1% to about 20% and, alternatively, from about 1% to about 10% bwocc. One of ordinary skill in the art, with the benefit of this disclosure, should recognize the appropriate amount of the pumicite to include for a chosen application.
Optionally, embodiments of the treatment fluids may further comprise a free water control additive. As used herein, the term “free water control additive” refers to an additive included in a liquid for, among other things, reducing (or preventing) the presence of free water in the liquid. Free water control additives may also reduce (or prevent) the settling of solids. Examples of suitable free water control additives include, but are not limited to, bentonite, amorphous silica, hydroxyethyl cellulose, and combinations thereof. An example of a suitable free water control additive is SA-1015™ suspending agent, available from Halliburton Energy Services, Inc. Another example of a suitable free water control additive is WG-17™ solid additive, available from Halliburton Energy Services, Inc. The free water control additive may be provided as a dry solid in some embodiments. Where used, the free water control additive may be present in an amount in the range of from about 0.1% to about 16% bwocc, for example. In alternative embodiments, the free water control additive may be present in an amount in the range of from about 0.1% to about 2% bwocc.
In some embodiments, the treatment fluids may further comprise a lightweight additive. The lightweight additive may be included to reduce the density of embodiments of the treatment fluids. For example, the lightweight additive may be used to foam a treatment fluid, for example, having a density of less than about 13 ppg. The lightweight additive typically may have a specific gravity of less than about 2.0. Examples of suitable lightweight additives may include sodium silicate, hollow microspheres, gilsonite, perlite, and combinations thereof. An example of a suitable sodium silicate is ECONOLITE™ additive, available from Halliburton Energy Services, Inc. Where used, the lightweight additive may be present in an amount in the range of from about 0.1% to about 20% bwocc, for example. In alternative embodiments, the lightweight additive may be present in an amount in the range of from about 1% to about 10% bwocc.
As previously mentioned, embodiments of the treatment fluids may be foamed with a gas, for example, to provide a treatment fluid with a reduced density. It should be understood that reduced densities may be needed in displacement embodiments to more approximately match the density of a particular drilling fluid, for example, where lightweight drilling fluids are being used. The drilling fluid 126 may be considered lightweight if it has a density of less than about 13 ppg, alternatively, less than about 10 ppg, and alternatively less than about 9 ppg. In some embodiments, the treatment fluids may be foamed to have a density within about 10% of the density of the drilling fluid 126 and, alternatively, within about 5% of the density of the drilling fluid 126. While techniques, such as lightweight additives, may be used to reduce the density of the treatment fluids comprising kiln dust without foaming, these techniques may have drawbacks. For example, reduction of the treatment fluid's density to below about 13 ppg using lightweight additives may produce unstable slurries, which can have problems with settling of solids, floating of lightweight additives, and free water, among others. Accordingly, the treatment fluid may be foamed to provide a treatment fluid having a reduced density that is more stable.
Therefore, in some embodiments, the treatment fluids may be foamed and comprise water, kiln dust, a foaming agent, and a gas. Optionally, to provide a treatment fluid with a lower density and more stable foam, the treatment fluid may further comprise a lightweight additive, for example. With the lightweight additive, a base slurry may be prepared that may then be foamed to provide an even lower density. In some embodiments, the foamed treatment fluid may have a density in the range of from about 4 ppg to about 13 ppg and, alternatively, about 7 ppg to about 9 ppg. In one particular embodiment, a base slurry may be foamed from a density of in the range of from about 9 ppg to about 13 ppg to a lower density, for example, in a range of from about 7 ppg to about 9 ppg.
The gas used in embodiments of the foamed treatment fluids may be any suitable gas for foaming the treatment fluid, including, but not limited to air, nitrogen, and combinations thereof. Generally, the gas should be present in embodiments of the foamed treatment fluids in an amount sufficient to form the desired foam. In certain embodiments, the gas may be present in an amount in the range of from about 5% to about 80% by volume of the foamed treatment fluid at atmospheric pressure, alternatively, about 5% to about 55% by volume, and, alternatively, about 15% to about 30% by volume.
Where foamed, embodiments of the treatment fluids may comprise a foaming agent for providing a suitable foam. As used herein, the term “foaming agent” refers to a material (e.g., surfactant) or combination of materials that facilitate the formation of a foam in a liquid, for example, by reduction of surface tension. Any suitable foaming agent for forming a foam in an aqueous liquid may be used in embodiments of the treatment fluids. Examples of suitable foaming agents may include, but are not limited to: mixtures of an ammonium salt of an alkyl ether sulfate, a cocoamidopropyl betaine surfactant, a cocoamidopropyl dimethylamine oxide surfactant, sodium chloride, and water; mixtures of an ammonium salt of an alkyl ether sulfate surfactant, a cocoamidopropyl hydroxysultaine surfactant, a cocoamidopropyl dimethylamine oxide surfactant, sodium chloride, and water; hydrolyzed keratin; mixtures of an ethoxylated alcohol ether sulfate surfactant, an alkyl or alkene amidopropyl betaine surfactant, and an alkyl or alkene dimethylamine oxide surfactant; aqueous solutions of an alpha-olefinic sulfonate surfactant and a betaine surfactant; and combinations thereof. An example of a suitable foaming agent is FOAMER™ 760 foamer/stabilizer, available from Halliburton Energy Services, Inc. Generally, the foaming agent may be present in embodiments of the foamed treatment fluids in an amount sufficient to provide a suitable foam. In some embodiments, the foaming agent may be present in an amount in the range of from about 0.8% to about 5% by volume of the water (“bvow”).
A wide variety of additional additives may be included in the treatment fluids as deemed appropriate by one skilled in the art, with the benefit of this disclosure. Examples of such additives include, but are not limited to: supplementary cementitious materials, weighting agents, viscosifying agents (e.g., clays, hydratable polymers, guar gum), fluid loss control additives, lost circulation materials, filtration control additives, dispersants, defoamers, corrosion inhibitors, scale inhibitors, formation conditioning agents, and water-wetting surfactant. Water-wetting surfactants may be used to aid in removal of oil from surfaces in the wellbore (e.g., the casing) to enhance cement and consolidating spacer fluid bonding. Examples of suitable weighting agents include, for example, materials having a specific gravity of 3 or greater, such as barite. Specific examples of these, and other, additives include: organic polymers, biopolymers, latex, ground rubber, surfactants, crystalline silica, amorphous silica, silica flour, fumed silica, nano-clays (e.g., clays having at least one dimension less than 100 nm), salts, fibers, hydratable clays, microspheres, rice husk ash, micro-fine cement (e.g., cement having an average particle size of from about 5 microns to about 10 microns), metakaolin, zeolite, shale, Portland cement, Portland cement interground with pumice, perlite, barite, slag, lime (e.g., hydrated lime), gypsum, and any combinations thereof, and the like. In some embodiments, a supplementary cementitious material may be included in the treatment fluid in addition to or in place of all or a portion of the kiln dust. Examples of suitable supplementary cementitious materials include, without limitation, Portland cement, Portland cement interground with pumice, micro-fine cement, fly ash, slag, pumicite, gypsum and any combination thereof. A person having ordinary skill in the art, with the benefit of this disclosure, will readily be able to detelinine the type and amount of additive useful for a particular application and desired result. It should be understood that, while the present disclosure describes a number of optional additives that may be included in the treatment fluids, it is intended to cover all combinations of the disclosed additives.
As previously mentioned, embodiments of the treatment fluids (e.g., cement composition 142, spacer fluid 140, etc.) may be consolidating in that the treatment fluids may develop gel strength and/or compressive strength in the wellbore 118. Consolidation is defined herein as one of three types of material behavior: Type 1 consolidation is identifiable as a gelled fluid that can be moved and/or pumped when the hydraulic shear stress exceeds the yield point (YP) of the gel. Type 2 consolidation is identifiable as a plastic semi-solid that can experience “plastic deformation” if the shear stress, compressive stress, or tensile stress exceeds the “plastic yield limit.” Type 3 consolidation is identifiable as a rigid solid similar to regular set cement. During a steady progressive strain rate during conventional compressive testing, both confined and unconfined, a Type 3 consolidated material would exhibit linear elastic Hookean stress-strain behavior, followed by some plastic yield and/or mechanical failure. The treatment fluid may transform from the pumpable fluid that was placed during the normal displacement operation to Type 1 and/or further progress to Type 2 and/or further progress to Type 3. It should be understood that the consolidation of the treatment fluid is at wellbore conditions and, as will be appreciated by those of ordinary skill in the art, wellbore conditions may vary. However, embodiments of the treatment fluids may be characterized by exhibiting Type 1, Type 2, or Type 3 consolidation under specific wellbore conditions.
Specific examples of how to characterize a Type 1 consolidation include measuring the yield stress. Type 1 consolidation exhibits a YP from about 25 Pascals to about 250 Pascals, where YP is measured by one of the methods described in U.S. Pat. No. 6,874,353, namely: using a series of parallel vertical blades on a rotor shaft, referred to by those skilled in the art as the “Vane Method”; or using the new device and method also described in U.S. Pat. No. 6,874,353. Another method used to define the YP of Type 1 consolidation is defined in Morgan, R. G., Suter, D. A., and Sweat, V. A., Mathematical Analysis of a Simple Back Extrusion Rheometer, ASAE Paper No. 79-6001. Additionally, other methods commonly known to those skilled in the art may be used to define the YP of Type 1 consolidated treatment fluid. Alternatively, another method of characterizing a Type 1 consolidation includes measuring the gelled strength of the material, which may be defined as “Static Gel Strength” (SGS) as is defined and measured in accordance with the API Recommended Practice on Determining the Static Gel Strength of Cement Formations, ANSI/API Recommended Practice 10B-6. A Type 1 consolidation may exhibit SGS values from about 70 lbf/100 ft2 up to about 500 lbf/100 ft2.
Specific examples of how to characterize a Type 2 consolidation include measuring the yield limit in compression (YL-C). The YL-C refers to the uniaxial compressive stress at which the material experiences a permanent deformation. Permanent deformation refers to a measurable deformation strain that does not return to zero over a period of time that is on the same order of magnitude as the total time required to conduct the measurement. YL-C may range from 1 psi (lbf/in2) to 2,000 psi, with the most common values ranging from 5 psi to 500 psi.
Specific examples of how to characterize a Type 3 consolidation include measuring the compressive strength. Type 3 consolidation will exhibit unconfined uniaxial compressive strengths ranging from about 5 psi to about 10,000 psi, while the most common values will range from about 10 psi to about 2,500 psi. These values are achieved in 7 days or less. Some formulations may be designed so as to provide significant compressive strengths within 24 hours to 48 hours. Typical sample geometry and sizes for measurement are similar to, but not limited to, those used for characterizing oil well cements: 2 inch cubes; or 2 inch diameter cylinders that are 4 inches in length; or 1 inch diameter cylinders that are 2 inches in length; and other methods known to those skilled in the art of measuring “mechanical properties” of oil well cements. For example, the compressive strength may be determined by crushing the samples in a compression-testing machine. The compressive strength is calculated from the failure load divided by the cross-sectional area resisting the load and is reported in units of pound-force per square inch (psi). Compressive strengths may be determined in accordance with API RP 10B-2, Recommended Practice for Testing Well Cements, First Edition, July 2005.
As a specific example of consolidation, when left in an annulus 130 (e.g., between walls of the wellbore 118 and the casing 108 or between the casing 108 and a larger conduit disposed in the wellbore 118), the treatment fluid may consolidate to develop static gel strength and/or compressive strength. The consolidated mass formed in the annulus 130 may act to support and position the casing 108 in the wellbore 118 and bond the exterior surface of the casing 108 to the walls of the wellbore 118 or to the larger conduit. The consolidated mass formed in the annulus 130 may also provide a substantially impermeable barrier to seal off formation fluids and gases and consequently also serve to mitigate potential fluid migration. The consolidated mass formed in the annulus 130 may also protect the casing 108 or other conduit from corrosion.
In some embodiments, consolidation of the treatment fluid (e.g., spacer fluid 140 or cement composition 142) in the wellbore 118 may be measured. The consolidation measurement may also include a measurement of the integrity of the bond formed between the consolidated treatment fluid and the exterior wall of the casing 108 and/or between the consolidated fluid and the walls of the wellbore 118 or larger conduit disposed in the wellbore 118. In some embodiments, data may be collected corresponding to the integrity of this bond, and the data may be recorded on a log, commonly referred to as a “bond long.” The bond log may be used to, for example, analyze the consolidation properties of the treatment fluid in the wellbore 118. Accordingly, embodiments may include running a cement bond log on at least the portion of the wellbore 118 containing the consolidated treatment fluid. The cement bond log for the consolidated treatment fluid may be obtained by any method used to measure cement integrity without limitation. In some embodiments, a tool may be run into the wellbore 118 on a wireline that can detect the bond of the consolidated treatment fluid to the casing 108 and/or the walls of the wellbore 118 (or larger conduit). An example of a suitable tool includes a sonic tool.
Embodiments of the treatments fluids (e.g., spacer fluid 140) may have a transition time that is shorter than the transition time of another fluid (e.g., cement composition 142) subsequently introduced into the wellbore 118. The term “transition time,” as used herein, refers to the time for a fluid to progress from a static gel strength of about 100 lbf/100 ft2 to about 500 lbf/100 ft2. By having a shorter transition time, the treatment fluid can reduce or even prevent migration of gas in the wellbore 118, even if gas migrates through a subsequently introduced cement composition 124 before it has developed sufficient gel strength to prevent such migration. Gas and liquid migration can typically be prevented at a static gel strength of 500 lbf/100 ft2. By reducing the amount of gas that can migrate through the wellbore 118, the subsequently added cement composition 142 can progress through its slower transition period without gas migration being as significant factor as the cement develops static gel strength. Some embodiments of the treatment fluids may have a transition time (i.e., the time to progress from a static gel strength of about 100 lbf/100 ft2 to about 500 lbf/100 ft2) at wellbore conditions of about 45 minutes or less, about 30 minutes or less, about 20 minutes or less, or about 10 minutes or less. Embodiments of the treatment fluids also quickly develop static gel strengths of about 100 lbf/100 ft2 and about 500 lbf/100 ft2, respectively, at wellbore conditions. The time for a fluid to a develop a static gel strength of about 100 lbf/100 ft2 is also referred to as the “zero gel time.” For example, the treatment fluids may have a zero gel time at wellbore condition of about 8 hours or less, and, alternatively, about 4 hours or less. In some embodiments, the treatment fluids may have a zero gel time in a range of from about 0 minutes to about 4 hours or longer. By way of further example, the treatment fluids may develop static gel strengths of about 500 lbf/100 ft2 or more at wellbore conditions in a time of from about 10 minutes to about 8 hours or longer. The preceding time for development of static gel strengths are listed as being at wellbore conditions. Those of ordinary skill in the art will understand that particular wellbore conditions (e.g., temperature, pressure, depth, etc.) will vary; however, embodiments of the treatment fluids should meet these specific requirements at the wellbore conditions. Static gel strength may be measured in accordance with API Recommended Practice on Determining the Static Gel Strength of Cement Formations, ANSI/API Recommended Practice 10B-6.
Embodiments of the treatment fluids may be prepared in accordance with any suitable technique. In some embodiments, the desired quantity of water may be introduced into a mixer (e.g., a cement blender) followed by the dry blend. The dry blend may comprise the kiln dust and additional solid additives, for example. Additional liquid additives, if any, may be added to the water as desired prior to, or after, combination with the dry blend. This mixture may be agitated for a sufficient period of time to form a base slurry. This base slurry may then be introduced into the wellbore 118 via pumps (e.g., cementing unit 144), for example. In the foamed embodiments, the base slurry may be pumped into the wellbore 118, and a foaming agent may be metered into the base slurry followed by injection of a gas, e.g., at a foam mixing “T,” in an amount sufficient to foam the base slurry thereby forming a foamed treatment fluid, in accordance with certain embodiments. After foaming, the foamed treatment fluid may be introduced into the wellbore 118. As will be appreciated by those of ordinary skill in the art, with the benefit of this disclosure, other suitable techniques for preparing treatment fluids may be used in accordance with the present disclosure.
In some embodiments, methods may include enhancing rheological properties of a treatment fluid (e.g., spacer fluid 140, cement composition 142, etc.). The method may comprise including kiln dust in a treatment fluid. Optional additives as described previously may also be included in the treatment fluid. The kiln dust may be included in the treatment fluid in an amount sufficient to provide a higher yield point than a first fluid. The higher yield point may be desirable, for example, to effectively displace the first fluid from the wellbore. As used herein, the term “yield point” refers to the resistance of a fluid to initial flow, or representing the stress required to start fluid movement. In an embodiment, the yield point of the treatment fluid at a temperature of up to about 180° F. is greater than about 5 lb/100 ft2. In an embodiment, the yield point of the treatment fluid at a temperature of up to about 180° F. is greater than about 10 lb/100 ft2. In an embodiment, the yield point of the treatment fluid at a temperature of up to about 180° F. is greater than about 20 lb/100 ft2. It may be desirable for the treatment fluid to not thermally thin to a yield point below the first fluid at elevated temperatures. Accordingly, the treatment fluid may have a higher yield point than the first fluid at elevated temperatures, such as 180° F. or bottom hole static temperature (“BHST”). In one embodiment, the treatment fluid may have a yield point that increases at elevated temperatures. For example, the treatment fluid may have a yield point that is higher at 180° F. than at 80° F. By way of further example. The treatment fluid may have a yield point that is higher at BHST than at 80° F.
In some embodiments, the treatment fluids may be used in the displacement of a drilling fluid 126 from a wellbore 118. The drilling fluid 126 may include, for example, any number of fluids, such as solid suspensions, mixtures, and emulsions. In some embodiments, the drilling fluid 126 may comprise an oil-based drilling fluid. An example of a suitable oil-based drilling fluid comprises an invert emulsion. In some embodiments, the oil-based drilling fluid may comprise an oleaginous fluid. Examples of suitable oleaginous fluids that may be included in the oil-based drilling fluids include, but are not limited to, α-olefins, internal olefins, alkanes, aromatic solvents, cycloalkanes, liquefied petroleum gas, kerosene, diesel oils, crude oils, gas oils, fuel oils, paraffin oils, mineral oils, low-toxicity mineral oils, olefins, esters, amides, synthetic oils (e.g., polyolefins), polydiorganosiloxanes, siloxanes, organosiloxanes, ethers, acetals, dialkylcarbonates, hydrocarbons, and combinations thereof.
To facilitate a better understanding of the present invention, the following examples of certain aspects of some embodiments are given. In no way should the following examples be read to limit, or define, the scope of the invention. In the following examples, concentrations are given in weight percent of the overall composition.
Sample treatment fluids were prepared to evaluate the rheological properties of spacer fluids containing kiln dust. In this example, cement kiln dust was used. The sample treatment fluids were prepared as follows. First, all dry components (e.g., cement kiln dust, fly ash, bentonite, free water control additive, etc.) were weighed into a glass container having a clean lid and agitated by hand until blended. Tap water was then weighed into a Waring blender jar. The dry components were then mixed into the water with 4,000 rpm stirring. The blender speed was then increased to 12,000 rpm for about 35 seconds.
Sample Spacer Fluid No. 1 was an 11 pound per gallon slurry that comprised 60.62% water, 34.17% cement kiln dust, 4.63% fly ash, and 0.58% free water control additive (WG-17™ solid additive).
Sample Spacer Fluid No. 2 was an 11 pound per gallon slurry that comprised 60.79% water, 30.42% cement kiln dust, 4.13% fly ash, 0.17% free water control additive (WG-17™ solid additive), 3.45% bentonite, and 1.04% Econolite™ additive.
Rheological values were then determined using a Fann Model 35 Viscometer. Dial readings were recorded at speeds of 3, 6, 100, 200, and 300 with a B1 bob, an R1 rotor, and a 1.0 spring. The dial readings, plastic viscosity, and yield points for the spacer fluids were measured in accordance with API Recommended Practices 10B, Bingham plastic model and are set forth in the table below. The abbreviation “PV” refers to plastic viscosity, while the abbreviation “YP” refers to yield point.
The thickening time of the Sample Fluid No. 1 was also determined in accordance with API Recommended Practice 10B at 205° F. Sample Fluid No. 1 had a thickening time of more than 6:00+ hours.
Accordingly, the above example illustrates that the addition of cement kiln dust to a treatment fluid may provide suitable properties for use in subterranean applications. In particular, the above example illustrates, inter alia, that the cement kiln dust may be used to provide a treatment fluid that may not exhibit thermal thinning with the treatment fluid potentially even having a yield point that increases with temperature. For example, Sample Fluid No. 2 had a higher yield point at 180° F. than at 80° F. In addition, the yield point of Sample Fluid No. 1 had only a slight decrease at 180° F. as compared to 80° F. Even further, the example illustrates that addition of the cement kiln dust to a treatment fluid may provide a plastic viscosity that increases with temperature.
Additional sample treatment fluids were prepared to further evaluate the rheological properties of spacer fluids containing kiln dust. Cement kiln dust was used in this example, The sample treatment fluids were prepared as follows. First, all dry components (e.g., cement kiln dust, fly ash) were weighed into a glass container having a clean lid and agitated by hand until blended. Tap water was then weighed into a Waring blender jar. The dry components were then mixed into the water with 4,000 rpm stirring. The blender speed was then increased to 12,000 rpm for about 35 seconds.
Sample Fluid No. 3 was a 12.5 pound per gallon fluid that comprised 47.29% water and 52.71% cement kiln dust.
Sample Fluid No. 4 was a 12.5 pound per gallon fluid that comprised 46.47% water, 40.15% cement kiln dust, and 13.38% fly ash.
Sample Fluid No. 5 was a 12.5 pound per gallon fluid that comprised 45.62% water, 27.19% cement kiln dust, and 27.19% fly ash.
Sample Fluid No. 6 was a 12.5 pound per gallon fluid that comprised 44.75% water, 13.81% cement kiln dust, and 41.44% fly ash.
Sample Fluid No. 7 (comparative) was a 12.5 pound per gallon fluid that comprised 43.85% water, and 56.15% fly ash.
Rheological values were then determined using a Fann Model 35 Viscometer. Dial readings were recorded at speeds of 3, 6, 30, 60, 100, 200, 300, and 600 with a B1 bob, an R1 rotor, and a 1.0 spring. The dial readings, plastic viscosity, and yield points for the spacer fluids were measured in accordance with API Recommended Practices 10B, Bingham plastic model and are set forth in the table below. The abbreviation “PV” refers to plastic viscosity, while the abbreviation “YP” refers to yield point.
Accordingly, the above example illustrates that the addition of the cement kiln dust to a treatment fluid may provide suitable properties for use in subterranean applications. In particular, the above example illustrates, inter alia, that the cement kiln dust may be used to provide a treatment fluid that may not exhibit thermal thinning with the treatment fluid potentially even having a yield point that increases with temperature. In addition, as illustrated in Table 2 above, higher yield points were observed for treatment fluids with higher concentrations of the cement kiln dust.
A sample treatment fluid containing kiln dust was prepared to compare the rheological properties of a treatment fluid containing kiln dust with an oil-based drilling fluid. In this example, cement kiln dust was used. The sample fluid was prepared as follows. First, all dry components (e.g., cement kiln dust, fly ash, bentonite, etc.) were weighed into a glass container having a clean lid and agitated by hand until blended. Tap water was then weighed into a Waring blender jar. The dry components were then mixed into the water with 4,000 rpm stirring. The blender speed was then increased to 12,000 rpm for about 35 seconds.
Sample Fluid No. 8 was an 11 pound per gallon slurry that comprised 60.79% water, 30.42% cement kiln dust, 4.13% fly ash, 0.17% free water control additive (WG-17™ solid additive), 3.45% bentonite, and 1.04% Econolite™ additive.
The oil-based drilling fluid was a 9.1 pound per gallon oil-based mud.
Rheological values were then determined using a Fann Model 35 Viscometer. Dial readings were recorded at speeds of 3, 6, 100, 200, and 300 with a B1 bob, an R1 rotor, and a 1.0 spring. The dial readings, plastic viscosity, and yield points for the spacer fluid and drilling fluid were measured in accordance with API Recommended Practices 10B, Bingham plastic model and are set forth in the table below. The abbreviation “PV” refers to plastic viscosity, while the abbreviation “YP” refers to yield point. The abbreviation “OBM” refers to oil-based mud.
Accordingly, the above example illustrates that the addition of cement kiln dust to a treatment fluid may provide suitable properties for use in subterranean applications. In particular, the above example illustrates, inter alia, that the cement kiln dust may be used to provide a treatment fluid with a yield point that is greater than a drilling fluid even at elevated temperatures. For example, Sample Fluid No. 8 has a higher yield point at 180° F. than the oil-based mud.
A foamed treatment fluid (Sample Fluid 9) was prepared that comprised cement kiln dust. First, a base slurry was prepared that had a density of 10 ppg and comprised cement kiln dust, a free water control additive (0.7% by weight of cement kiln dust), a lightweight additive (4% by weight of cement kiln dust), and fresh water (32.16 gallons per 94-pound sack of cement kiln dust). The free water control additive was SA-1015™ suspending aid. The lightweight additive was ECONOLITE™ additive. Next, a foaming agent (FOAMER™ 760 foamer/stabilizer) in an amount of 2% bvow was added, and the base slurry was then mixed in a foam blending jar for 4 seconds at 12,000 rpm. The resulting foamed treatment fluid had a density of 8.4 ppg. The “sink” of the resultant foamed treatment fluid was then measured using a free fluid test procedure as specified in API Recommended Practice 10B. However, rather than measuring the free fluid, the amount of “sink” was measured after the foamed treatment fluid remained static for a period of 2 hours. The foamed treatment fluid was initially at 200° and cooled to ambient temperature over the 2-hour period. The measured sink for this foamed treatment fluid was 5 millimeters.
Another foamed treatment fluid (Sample Fluid 10) was prepared that comprised cement kiln dust. First, a base slurry was prepared that had a density of 10.5 ppg and comprised cement kiln dust, a free water control additive (0.6% by weight of cement kiln dust), a lightweight additive (4% by weight of cement kiln dust), and fresh water (23.7 gallons per 94-pound sack of cement kiln dust). The free water control additive was SA-1015™ suspending aid. The lightweight additive was ECONOLITE™ additive. Next, a foaming agent (a hexylene glycol/cocobetaine blended surfactant) in an amount of 2% bvow was added, and the base slurry was then mixed in a foam blending jar for 6 seconds at 12,000 rpm. The resulting foamed treatment fluid had a density of 8.304 ppg. The resultant foamed treatment fluid had a sink of 0 millimeters, measured as described above for Example 4.
The following series of tests were performed to determine the compressive strength of sample treatment fluids after consolidation. Twenty-two samples, labeled sample fluids 11-32 in the table below, were prepared having a density of 12.5 ppg using various concentrations of additives. The amount of these additives in each sample fluid are indicated in the table below with “% by weight” indicating the amount of the particular component by weight of Additive 1+Additive 2. The abbreviation “gal/sk” in the table below indicates gallons of the particular component per 94-pound sack of Additive 1 and Additive 2.
The cement kiln dust used was supplied by Holcim (US) Inc., from Ada, Okla. The shale used was supplied by Texas Industries, Inc., from Midlothian, Tex. The pumice used was either DS-200 or DS-300 lightweight aggregate available from Hess Pumice Products, Inc. The silica flour used was SSA-1™ cement additive, from Halliburton Energy Services, Inc. The course silica flour used was SSA-2™ course silica flour, from Halliburton Energy Services, Inc. The metakaolin used was MetaMax® metakaolin, from BASF. The amorphous silica used was SILICALITE™ cement additive, from Halliburton Energy Services, Inc. The perlite used was supplied by Hess Pumice Products, Inc. The slag used was supplied by LaFarge North America. The Portland cement Interground with pumice was FineCem™ cement, from Halliburton Energy Services, Inc. The fly ash used was POZMIX® cement additive, from Halliburton Energy Services, Inc. The micro-fine cement used was MICRO MATRIX® cement having an average particle size of 7.5 microns, from Halliburton Energy Services, Inc. The rice husk ash used was supplied by Rice Hull Specialty Products, Stuttgart, Ark. The biopolymer used was supplied by CP Kelco, San Diego, Calif. The barite used was supplied by Baroid Industrial Drilling Products. The latex used was Latex 3000™ cement additive from Halliburton Energy Services, Inc. The ground rubber used was LIFECEM™ 100 cement additive from Halliburton Energy Services, Inc. The nano-clay used was supplied by Nanocor Inc. The set retarder used was SCR-100™ cement retarder, from Halliburton Energy Services, Inc. SCR-100™ cement retarder is a copolymer of acrylic acid and 2-acrylamido-2-methylpropane sulfonic acid.
After preparation, the sample fluids were allowed to cure for seven days in a 2″ by 4″ metal cylinder that was placed in a water bath at 180° F. to form set cylinders. Immediately after removal from the water bath, destructive compressive strengths were determined using a mechanical press in accordance with API RP 10B-2. The results of these tests are set forth below. The term “cement kiln dust” is abbreviated “CKD” in the table below.
Accordingly, the above example illustrates that a treatment fluid comprising kiln dust may be capable of consolidation. For example, 7-day compressive strengths of 1000 psi or even higher were observed for certain sample slurries.
The following series of tests were performed to evaluate the thickening times of sample treatment fluids. For this example, the thickening times for Sample Fluids 11-32 from Example 6 were determined. As indicated below, the compositions for Samples Fluids 11-32 were the same as from Example 6 except the concentration of the cement set retarder was adjusted for certain samples. The thickening time, which is the time required for the compositions to reach 70 Bearden units of consistency, was determined for each fluid at 230° F. in accordance with API RP 10B-2. The results of these tests are set forth below. The term “cement kiln dust” is abbreviated “CKD” in the table below.
Accordingly, the above example illustrates that a settable spacer fluid may have acceptable thickening times for certain applications.
The following series of tests were performed to evaluate the rheological properties of sample fluids. For this example, the rheological properties of Sample Fluids 11-32 were determined. The rheological values were determined using a Fann Model 35 Viscometer. Dial readings were recorded at speeds of 3, 6, 30, 60, 100, 200, 300, and 600 with a B1 bob, an R1 rotor, and a 1.0 spring. An additional sample was used for this specific test. It is Sample Fluid 33 and comprised barite and 0.5% of a suspending agent by weight of the barite. The suspending agent was SA™-1015, available from Halliburton Energy Services, Inc. The water was included in an amount sufficient to provide a density of 12.5 ppg. Sample 33's rheological properties were measured twice at two different temperatures and the values per temperature were averaged to present the data shown below. Temperature is measured in degrees Fahrenheit. The results of these tests are set forth below.
Accordingly, the above example indicates that a treatment fluid may have acceptable rheological properties for a particular application.
The following series of tests were performed to further evaluate the compressive strength of sample treatment fluids. Ten samples, labeled Sample Fluids 34-43 in the table below were prepared, having a density of 13 ppg using various concentrations of additives. The amount of these additives in each sample are indicated in the table below with “% by weight” indicating the amount of the particular component by weight of the dry solids, which is the kiln dust, the Portland cement, the cement accelerator, the fly ash, and/or the lime. The abbreviation “gal/sk” in the table below indicates gallons of the particular component per 94-pound sack of the dry solids. The term “cement kiln dust” is abbreviated “CKD” in the table below.
The cement kiln dust used was Mountain cement kiln dust from Laramie Wyo., except for Sample Fluid 43 which used cement kiln dust from Holcim (US) Inc., Ada, Okla. The Portland cement used in Sample Fluids 34 and 35 was CEMEX Type 3 Portland cement, from CEMEX USA. The cement accelerator used in Sample Fluid 34 was CAL-SEAL™ accelerator, from Halliburton Energy Services Inc. CAL-SEAL™ Accelerator is gypsum. The Class F fly ash used in Slurries 37-41 was from Coal Creek Station. The Class C fly ash used in Slurries 36 was from LaFarge North America.
After preparation, the samples were allowed to cure for twenty-four or forty-eight hours in a 2″ by 4″ metal cylinder that was placed in a water bath at 160° F. to form set cylinders. For certain samples, separate cylinders were cured for twenty-four hours and forty-eight hours. Immediately after removal from the water bath, destructive compressive strengths were determined using a mechanical press in accordance with API RP 10B-2. The results of these tests are set forth below.
Accordingly, the above example illustrates that a treatment fluid may have acceptable compressive strengths for certain applications.
The following series of tests were performed to evaluate the static gel strength development of sample treatment fluids. Two samples, labeled Sample Fluids 44 and 45 were prepared having a density of 11 and 13.5 ppg respectively using various concentrations of additives. The component concentrations of each sample are as follows:
For Sample Fluid 44, the sample comprised a blend of cement kiln dust (80% by weight), fly ash (16% by weight) and hydrated lime (4% by weight). The sample also comprised a suspending aid in an amount of 0.4% by weight of the blend. Sufficient water was included in the sample to provide a density of 11 ppg. The cement kiln dust used was from Holcim (US) Inc., Ada, Okla. The fly ash used was POZMIX® cement additive, from Halliburton Energy Services, Inc. The suspending agent was SA™-1015 suspending agent, available from Halliburton Energy Services, Inc.
For Sample Fluid 45, the sample comprised a mixture of cement kiln dust (80% by weight), fly ash (16% by weight), and hydrate lime (4% by weight). Sufficient water was included in the sample to provide a density of 13.5 ppg. The cement kiln dust used was from Holcim (US) Inc., Ada, Okla. The fly ash used was POZMIX® cement additive, from Halliburton Energy Services, Inc.
The static gel strength of the samples was measured in accordance with API Recommended Practice on Determining the Static Gel Strength of Cement Formations, ANSI/API Recommended Practice 10B-6.
The following tests were performed to further evaluate the static gel strength development of sample treatment fluids. Two samples, labeled Samples Fluids 46 and 47 were prepared having a density of 13.002 and 10.999 ppg respectively using various concentrations of additives. The component concentrations of each sample are as follows:
For Sample Fluid 46, the sample comprised a blend of cement kiln dust (100% by weight), POZMIX® cement additive (50% by weight of the cement kiln dust), He-601 cement retarder (1% by weight of the cement kiln dust), HR®-25 cement retarder (0.6% by weight of the cement kiln dust), and D-Air 5000™ defoamer (0.5% by weight of the cement kiln dust). Sufficient water was included in the sample to provide a density of 13.002 ppg. The cement kiln dust used was from Holcim (US) Inc., Ada, Okla. POZMIX® cement additive was from Halliburton Energy Services, Inc. HR®-601 cement retarder was from Halliburton Energy Services, Inc. HR®-25 cement retarder was from Halliburton Energy Services, Inc. D-Air 5000™ defoamer was from Halliburton Energy Services, Inc.
For Sample Fluid 47, the sample comprised a blend of cement kiln dust (100% by weight), SA-1015 (0.4% by weight of the cement kiln dust), and D-Air 5000™ defoamer (0.5% by weight of the cement kiln dust). Sufficient water was included in the sample to provide a density of 10.999 ppg. The cement kiln dust used was from Holcim (US) Inc., Ada, Okla. SA™-1015 suspending agent was from Halliburton Energy Services, Inc. D-Air 5000™ defoamer was from Halliburton Energy Services, Inc.
The static gel strength of the samples was measured in accordance with API Recommended Practice on Determining the Static Gel Strength of Cement Formations, ANSI/API Recommended Practice 10B-6. Table 8 shows the static gel strength measurements for Samples Fluids 46 and 47, respectively.
As seen in the table, Sample Fluid 47 progresses through the transition time, defined as the time between 100 SGS and 500 SGS, very quickly with a total transition time of 10 minutes. Sample Fluid 46 is much slower taking over an hour to progress through the transition time. The short transition time of Sample Fluid 47 is faster than most cement compositions.
It should be understood that the compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. Moreover, the indefinite articles “a” or “an,” as used in the claims, are defined herein to mean one or more than one of the element that it introduces.
For the sake of brevity, only certain ranges are explicitly disclosed herein. However, ranges from any lower limit may be combined with any upper limit to recite a range not explicitly recited, as well as, ranges from any lower limit may be combined with any other lower limit to recite a range not explicitly recited, in the same way, ranges from any upper limit may be combined with any other upper limit to recite a range not explicitly recited. Additionally, whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range are specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values even if not explicitly recited. Thus, every point or individual value may serve as its own lower or upper limit combined with any other point or individual value or any other lower or upper limit, to recite a range not explicitly recited.
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Although individual embodiments are discussed, the invention covers all combinations of all those embodiments. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. If there is any conflict in the usages of a word or term in this specification and one or more patent(s) or other documents that may be incorporated herein by reference, the definitions that are consistent with this specification should be adopted.
This application is a divisional application of U.S. patent application Ser. No. 14/091,332, filed Nov. 26, 2013, which is a continuation-in-part of U.S. patent application Ser. No. 13/851,925, filed Mar. 27, 2013, which is a divisional application of U.S. patent application Ser. No. 13/725,833, filed Dec. 21, 2012, issued as U.S. Pat. No. 8,505,630 on Aug. 13, 2013, which is a continuation-in-part of U.S. application Ser. No. 13/535,145, filed Jun. 27, 2012, issued as U.S. Pat. No. 8,505,629 on Aug. 13, 2013, which is a continuation-in-part of U.S. application Ser. No. 12/895,436, filed Sep. 30, 2010, issued as U.S. Pat. No. 8,522,872 on Sep. 3, 2013, which is a continuation-in-part of U.S. application Ser. No. 12/264,010, filed Nov. 3, 2008, issued as U.S. Pat. No. 8,333,240 on Dec. 18, 2012, which is a continuation-in-part of U.S. application Ser. No. 11/223,669, filed Sep. 9, 2005, issued as U.S. Pat. No. 7,445,669 on Nov. 4, 2008, the entire disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1931921 | Breerwood | Oct 1933 | A |
2021956 | Gladney et al. | Nov 1935 | A |
2045899 | Davis | Jun 1936 | A |
2094316 | Cross et al. | Sep 1937 | A |
2133622 | Larmour et al. | Oct 1938 | A |
2144254 | Breerwood | Jan 1939 | A |
2193775 | Stratford | Mar 1940 | A |
2193807 | Dieterich | Mar 1940 | A |
2214715 | Breerwood | Sep 1940 | A |
2329940 | Ponzer | Sep 1943 | A |
2592468 | Rex et al. | Apr 1952 | A |
2772739 | Arie | Dec 1956 | A |
2842205 | Allen et al. | Jul 1958 | A |
2844361 | Dilcher et al. | Jul 1958 | A |
2848051 | Willaims | Aug 1958 | A |
2871133 | Palonen et al. | Jan 1959 | A |
2880096 | Hurley | Mar 1959 | A |
2945769 | Gama et al. | Jul 1960 | A |
3024125 | Lee | Mar 1962 | A |
3066031 | Schifferle | Nov 1962 | A |
3168139 | Kennedy et al. | Feb 1965 | A |
3320077 | Prior | May 1967 | A |
3411580 | Roberts et al. | Nov 1968 | A |
3421703 | Galer | Jan 1969 | A |
3454095 | Messenger et al. | Jul 1969 | A |
3467193 | Messenger | Sep 1969 | A |
3473939 | Mayberry et al. | Oct 1969 | A |
3499491 | Wyant et al. | Mar 1970 | A |
3557876 | Tragesser | Jan 1971 | A |
3574113 | Shannon | Apr 1971 | A |
3574816 | Abbdellatif et al. | Apr 1971 | A |
3628973 | Greening et al. | Dec 1971 | A |
3748159 | George | Jul 1973 | A |
3749173 | Hill et al. | Jul 1973 | A |
3863718 | Bruist | Feb 1975 | A |
3876005 | Fincher et al. | Apr 1975 | A |
3887009 | Miller et al. | Jun 1975 | A |
3887385 | Quist et al. | Jun 1975 | A |
3921717 | Danjushevsky et al. | Nov 1975 | A |
3959007 | Pitt | May 1976 | A |
4018617 | Nicholson | Apr 1977 | A |
4018619 | Webster et al. | Apr 1977 | A |
4031184 | McCord | Jun 1977 | A |
4036301 | Powers et al. | Jul 1977 | A |
4083407 | Griffin et al. | Apr 1978 | A |
4101332 | Nicholson | Jul 1978 | A |
4105459 | Mehta | Aug 1978 | A |
4141843 | Watson | Feb 1979 | A |
4160674 | Sawyer | Jul 1979 | A |
4176720 | Wilson | Dec 1979 | A |
4268316 | Wills | May 1981 | A |
4274881 | Langton | Jun 1981 | A |
4304300 | Watson | Dec 1981 | A |
4333764 | Richardson | Jun 1982 | A |
4341562 | Ahlbeck | Jul 1982 | A |
RE31190 | Detroit et al. | Mar 1983 | E |
4400474 | Copperthwaite et al. | Aug 1983 | A |
4407677 | Wills, Jr. | Oct 1983 | A |
4423781 | Thomas | Jan 1984 | A |
4432800 | Kneller et al. | Feb 1984 | A |
4435216 | Diehl et al. | Mar 1984 | A |
4436850 | Burdick et al. | Mar 1984 | A |
4440576 | Flannery et al. | Apr 1984 | A |
4460292 | Durham et al. | Jul 1984 | A |
4462835 | Car | Jul 1984 | A |
4470463 | Holland | Sep 1984 | A |
4494990 | Harris | Jan 1985 | A |
4515635 | Rao et al. | May 1985 | A |
4519452 | Tsao et al. | May 1985 | A |
4555269 | Rao et al. | Nov 1985 | A |
4614599 | Walker | Sep 1986 | A |
4624711 | Styron | Nov 1986 | A |
4633950 | Delhommer et al. | Jan 1987 | A |
4676317 | Fry et al. | Jun 1987 | A |
4676832 | Childs et al. | Jun 1987 | A |
4741782 | Styron | May 1988 | A |
4784223 | Worrall et al. | Nov 1988 | A |
4829107 | Kindt et al. | May 1989 | A |
4883125 | Wilson et al. | Nov 1989 | A |
4941536 | Brothers et al. | Jul 1990 | A |
4992102 | Barbour | Feb 1991 | A |
5030366 | Wilson et al. | Jul 1991 | A |
5049288 | Brothers et al. | Sep 1991 | A |
5058679 | Hale et al. | Oct 1991 | A |
RE33747 | Hartley et al. | Nov 1991 | E |
5086850 | Harris et al. | Feb 1992 | A |
5113943 | Wilson et al. | May 1992 | A |
5121795 | Ewert et al. | Jun 1992 | A |
5123487 | Harris et al. | Jun 1992 | A |
5125455 | Harris et al. | Jun 1992 | A |
5127473 | Harris et al. | Jul 1992 | A |
5183505 | Spinney | Feb 1993 | A |
5183506 | Zhang | Feb 1993 | A |
5213160 | Nahm et al. | May 1993 | A |
5215585 | Luthra et al. | Jun 1993 | A |
5238064 | Dahl et al. | Aug 1993 | A |
5252128 | Gopalkrishnan | Oct 1993 | A |
5266111 | Barbour | Nov 1993 | A |
5290355 | Jakel et al. | Mar 1994 | A |
5295543 | Terry et al. | Mar 1994 | A |
5305831 | Nahm | Apr 1994 | A |
5314022 | Cowan et al. | May 1994 | A |
5316083 | Nahm et al. | May 1994 | A |
5327968 | Onan et al. | Jul 1994 | A |
5337824 | Cowan | Aug 1994 | A |
5339902 | Harris | Aug 1994 | A |
5346548 | Mehta | Sep 1994 | A |
5352288 | Mallow | Oct 1994 | A |
5358044 | Hale et al. | Oct 1994 | A |
5358049 | Hale et al. | Oct 1994 | A |
5361841 | Hale et al. | Nov 1994 | A |
5361842 | Hale et al. | Nov 1994 | A |
5368103 | Heathman et al. | Nov 1994 | A |
5370185 | Cowan et al. | Dec 1994 | A |
5372641 | Carpenter | Dec 1994 | A |
5382290 | Nahm et al. | Jan 1995 | A |
5383521 | Onan et al. | Jan 1995 | A |
5383967 | Chase | Jan 1995 | A |
5398758 | Onan et al. | Mar 1995 | A |
5417759 | Huddleston | May 1995 | A |
5421409 | Mueller et al. | Jun 1995 | A |
5423379 | Hale et al. | Jun 1995 | A |
5430235 | Hooykaas et al. | Jul 1995 | A |
5439056 | Cowan | Aug 1995 | A |
5454867 | Brothers et al. | Oct 1995 | A |
5456751 | Zandi et al. | Oct 1995 | A |
5458195 | Totten et al. | Oct 1995 | A |
5464060 | Hale et al. | Nov 1995 | A |
5472051 | Brothers | Dec 1995 | A |
5476144 | Nahm et al. | Dec 1995 | A |
5478391 | Babaev et al. | Dec 1995 | A |
5484019 | Griffith | Jan 1996 | A |
5494513 | Fu et al. | Feb 1996 | A |
5499677 | Cowan | Mar 1996 | A |
5515921 | Cowan et al. | May 1996 | A |
5518996 | Maroy et al. | May 1996 | A |
5520730 | Barbour | May 1996 | A |
5529123 | Carpenter et al. | Jun 1996 | A |
5529624 | Riegler | Jun 1996 | A |
5536311 | Rodrigues | Jul 1996 | A |
5542782 | Carter et al. | Aug 1996 | A |
5554352 | Jaques et al. | Sep 1996 | A |
5569324 | Totten et al. | Oct 1996 | A |
5571318 | Griffith et al. | Nov 1996 | A |
5580379 | Cowan | Dec 1996 | A |
5584926 | Borgholm et al. | Dec 1996 | A |
5585333 | Dahl et al. | Dec 1996 | A |
5588489 | Chatterji et al. | Dec 1996 | A |
5641584 | Andersen et al. | Jun 1997 | A |
5673753 | Hale et al. | Oct 1997 | A |
5681384 | Liskowitz et al. | Oct 1997 | A |
5688844 | Chatterji et al. | Nov 1997 | A |
5711383 | Terry et al. | Jan 1998 | A |
5716910 | Totten et al. | Feb 1998 | A |
5728654 | Dobson et al. | Mar 1998 | A |
5789352 | Carpenter et al. | Aug 1998 | A |
5795924 | Chatterji et al. | Aug 1998 | A |
5820670 | Chatterji et al. | Oct 1998 | A |
5851960 | Totten et al. | Dec 1998 | A |
5866516 | Costin | Feb 1999 | A |
5866517 | Carpenter et al. | Feb 1999 | A |
5874387 | Carpenter et al. | Feb 1999 | A |
5897699 | Chatterji et al. | Apr 1999 | A |
5900053 | Brothers et al. | May 1999 | A |
5913364 | Sweatman | Jun 1999 | A |
5968255 | Mehta et al. | Oct 1999 | A |
5988279 | Udarbe et al. | Nov 1999 | A |
6022408 | Stokes et al. | Feb 2000 | A |
6060434 | Sweatman et al. | May 2000 | A |
6060535 | Villar et al. | May 2000 | A |
6063738 | Chatterji et al. | May 2000 | A |
6098711 | Chatterji et al. | Aug 2000 | A |
6138759 | Chatterji et al. | Oct 2000 | A |
6143069 | Brothers et al. | Nov 2000 | A |
6145591 | Boncan et al. | Nov 2000 | A |
6153562 | Villar et al. | Nov 2000 | A |
6167967 | Sweatman | Jan 2001 | B1 |
6170575 | Reddy et al. | Jan 2001 | B1 |
6230804 | Mueller et al. | May 2001 | B1 |
6244343 | Brothers et al. | Jun 2001 | B1 |
6245142 | Reddy et al. | Jun 2001 | B1 |
6258757 | Sweatman et al. | Jul 2001 | B1 |
6264738 | Lorke et al. | Jul 2001 | B1 |
6277189 | Chugh | Aug 2001 | B1 |
6312515 | Barlet-Gouedard et al. | Nov 2001 | B1 |
6315042 | Griffith et al. | Nov 2001 | B1 |
6328106 | Griffith et al. | Dec 2001 | B1 |
6332921 | Brothers et al. | Dec 2001 | B1 |
6367550 | Chatterji et al. | Apr 2002 | B1 |
6379456 | Heathman et al. | Apr 2002 | B1 |
6402833 | O'Hearn et al. | Jun 2002 | B1 |
6409819 | Ko | Jun 2002 | B1 |
6416574 | Steelhammer et al. | Jul 2002 | B1 |
6451104 | Mehta | Sep 2002 | B2 |
6457524 | Roddy | Oct 2002 | B1 |
6478869 | Reddy et al. | Nov 2002 | B2 |
6478870 | Marko | Nov 2002 | B2 |
6488763 | Brothers et al. | Dec 2002 | B2 |
6488764 | Westerman | Dec 2002 | B2 |
6494951 | Reddy et al. | Dec 2002 | B1 |
6500252 | Chatterji et al. | Dec 2002 | B1 |
6502634 | Evans et al. | Jan 2003 | B1 |
6508305 | Brannon et al. | Jan 2003 | B1 |
6516884 | Chatterji et al. | Feb 2003 | B1 |
6524384 | Griffith et al. | Feb 2003 | B2 |
6547871 | Chatterji et al. | Apr 2003 | B2 |
6547891 | Linden et al. | Apr 2003 | B2 |
6555307 | Maruyama | Apr 2003 | B2 |
6561273 | Brothers et al. | May 2003 | B2 |
6562122 | Dao et al. | May 2003 | B2 |
6565647 | Day et al. | May 2003 | B1 |
6572697 | Gleeson et al. | Jun 2003 | B2 |
6610139 | Reddy et al. | Aug 2003 | B2 |
6626243 | Go Boncan | Sep 2003 | B1 |
6641658 | Dubey | Nov 2003 | B1 |
6645289 | Sobolev et al. | Nov 2003 | B2 |
6645290 | Barbour | Nov 2003 | B1 |
6656265 | Garnier et al. | Dec 2003 | B1 |
6660080 | Reddy et al. | Dec 2003 | B2 |
6666268 | Griffith et al. | Dec 2003 | B2 |
6668927 | Chatterji et al. | Dec 2003 | B1 |
6668929 | Griffith et al. | Dec 2003 | B2 |
6689208 | Brothers | Feb 2004 | B1 |
6702044 | Reddy et al. | Mar 2004 | B2 |
6706108 | Polston | Mar 2004 | B2 |
6708760 | Chatterji et al. | Mar 2004 | B1 |
6715568 | Bailey | Apr 2004 | B1 |
6716282 | Griffith et al. | Apr 2004 | B2 |
6729405 | DiLullo et al. | May 2004 | B2 |
6749679 | Shi | Jun 2004 | B2 |
6755905 | Oates | Jun 2004 | B2 |
6767398 | Trato | Jul 2004 | B2 |
6776237 | Dao et al. | Aug 2004 | B2 |
6796378 | Reddy et al. | Sep 2004 | B2 |
6797054 | Chatterji et al. | Sep 2004 | B2 |
6823940 | Reddy et al. | Nov 2004 | B2 |
6832652 | Dillenbeck et al. | Dec 2004 | B1 |
6835243 | Brothers et al. | Dec 2004 | B2 |
6837316 | Reddy et al. | Jan 2005 | B2 |
6840318 | Lee | Jan 2005 | B2 |
6840996 | Morioka et al. | Jan 2005 | B2 |
6846357 | Reddy et al. | Jan 2005 | B2 |
6848519 | Reddy et al. | Feb 2005 | B2 |
6869474 | Perez-Pena | Mar 2005 | B2 |
6869475 | Krowl | Mar 2005 | B1 |
6874353 | Johnson | Apr 2005 | B2 |
6874578 | Garnier | Apr 2005 | B1 |
6883609 | Drochon | Apr 2005 | B2 |
6887833 | Brothers et al. | May 2005 | B2 |
6889767 | Reddy et al. | May 2005 | B2 |
6899177 | Chatterj et al. | May 2005 | B2 |
6904971 | Brothers et al. | Jun 2005 | B2 |
6908507 | Lalande et al. | Jun 2005 | B2 |
6908508 | Brothers | Jun 2005 | B2 |
6911078 | Barlet-Gouedard et al. | Jun 2005 | B2 |
6964302 | Luke et al. | Nov 2005 | B2 |
6989057 | Getzlaf et al. | Jan 2006 | B2 |
7004263 | Moriarty et al. | Feb 2006 | B2 |
7022755 | Chatterji et al. | Apr 2006 | B1 |
7048053 | Santra et al. | May 2006 | B2 |
7055603 | Caveny et al. | Jun 2006 | B2 |
7073584 | Reddy et al. | Jul 2006 | B2 |
7073585 | Morgan et al. | Jul 2006 | B2 |
7077203 | Roddy et al. | Jul 2006 | B1 |
7096944 | Vargo et al. | Aug 2006 | B2 |
7101829 | Guichard et al. | Sep 2006 | B2 |
7137446 | Gagliano et al. | Nov 2006 | B2 |
7140439 | Luke et al. | Nov 2006 | B2 |
7140440 | Luke et al. | Nov 2006 | B2 |
7143827 | Chatterji et al. | Dec 2006 | B2 |
7147055 | Brothers et al. | Dec 2006 | B2 |
7147067 | Getzlaf et al. | Dec 2006 | B2 |
7150321 | Luke et al. | Dec 2006 | B2 |
7174962 | Roddy et al. | Feb 2007 | B1 |
7182137 | Fyten et al. | Feb 2007 | B2 |
7198104 | Griffith et al. | Apr 2007 | B2 |
7199086 | Roddy et al. | Apr 2007 | B1 |
7204307 | Roddy et al. | Apr 2007 | B2 |
7204310 | Roddy et al. | Apr 2007 | B1 |
7213646 | Roddy et al. | May 2007 | B2 |
7217441 | Bour et al. | May 2007 | B2 |
7219733 | Luke et al. | May 2007 | B2 |
7255739 | Brothers et al. | Aug 2007 | B2 |
7284609 | Roddy et al. | Oct 2007 | B2 |
7284930 | Shi et al. | Oct 2007 | B2 |
7285164 | Luke et al. | Oct 2007 | B2 |
7285166 | Luke et al. | Oct 2007 | B2 |
7293609 | Dealy et al. | Nov 2007 | B2 |
7297664 | Santra et al. | Nov 2007 | B2 |
7303008 | Badalamenti et al. | Dec 2007 | B2 |
7316744 | De La Roij et al. | Jan 2008 | B2 |
7325611 | Santra et al. | Feb 2008 | B2 |
7335252 | Roddy et al. | Feb 2008 | B2 |
7337842 | Roddy et al. | Mar 2008 | B2 |
7338923 | Roddy et al. | Mar 2008 | B2 |
7341104 | Roddy et al. | Mar 2008 | B2 |
7341105 | Bingamon et al. | Mar 2008 | B2 |
7350573 | Reddy | Apr 2008 | B2 |
7353870 | Roddy et al. | Apr 2008 | B2 |
7381263 | Roddy et al. | Jun 2008 | B2 |
7387675 | Roddy et al. | Jun 2008 | B2 |
7395860 | Roddy et al. | Jul 2008 | B2 |
7404855 | Chatterji et al. | Jul 2008 | B2 |
7409990 | Burts et al. | Aug 2008 | B1 |
7413014 | Chatterji et al. | Aug 2008 | B2 |
7442249 | Mueller | Oct 2008 | B2 |
7445669 | Roddy et al. | Nov 2008 | B2 |
7478675 | Roddy et al. | Jan 2009 | B2 |
7527688 | Bingamon et al. | May 2009 | B2 |
7544640 | Luke et al. | Jun 2009 | B2 |
7607482 | Roddy et al. | Oct 2009 | B2 |
7607484 | Roddy et al. | Oct 2009 | B2 |
7627870 | Michaeli et al. | Dec 2009 | B1 |
7631692 | Roddy et al. | Dec 2009 | B2 |
7651563 | Datta et al. | Jan 2010 | B2 |
7655088 | Bethani | Feb 2010 | B2 |
7658796 | Nordmeyer | Feb 2010 | B2 |
7674332 | Roddy et al. | Mar 2010 | B2 |
7708071 | Roddy et al. | May 2010 | B2 |
7712527 | Roddy | May 2010 | B2 |
7740070 | Santra et al. | Jun 2010 | B2 |
7741841 | Edwards et al. | Jun 2010 | B2 |
7743828 | Roddy et al. | Jun 2010 | B2 |
7748454 | Roddy et al. | Jul 2010 | B2 |
7757766 | Lewis et al. | Jul 2010 | B2 |
7784542 | Roddy et al. | Aug 2010 | B2 |
7789150 | Roddy et al. | Sep 2010 | B2 |
7815880 | Constantz et al. | Oct 2010 | B2 |
7837412 | O'Hearn | Nov 2010 | B2 |
7867954 | Warrender et al. | Jan 2011 | B2 |
7887694 | Constantz et al. | Feb 2011 | B2 |
7919064 | Kawatra et al. | Apr 2011 | B2 |
7922809 | Constantz et al. | Apr 2011 | B1 |
7927419 | Roddy | Apr 2011 | B2 |
7938201 | Giroux et al. | May 2011 | B2 |
7939336 | Constantz et al. | May 2011 | B2 |
7963323 | Bailey | Jun 2011 | B2 |
7993451 | Brouillette et al. | Aug 2011 | B2 |
8006446 | Constantz et al. | Aug 2011 | B2 |
8029618 | Al-Shafei | Oct 2011 | B2 |
8030253 | Roddy et al. | Oct 2011 | B2 |
8039253 | Asou et al. | Oct 2011 | B2 |
8062999 | Reddy et al. | Nov 2011 | B2 |
8143198 | Lewis et al. | Mar 2012 | B2 |
8162055 | Lewis et al. | Apr 2012 | B2 |
8186457 | Boyle | May 2012 | B2 |
8261827 | Roddy et al. | Sep 2012 | B2 |
8281859 | Roddy et al. | Oct 2012 | B2 |
8297357 | Brenneis et al. | Oct 2012 | B2 |
8307899 | Brenneis et al. | Nov 2012 | B2 |
8318642 | Roddy et al. | Nov 2012 | B2 |
8324137 | Roddy et al. | Dec 2012 | B2 |
8327939 | Roddy | Dec 2012 | B2 |
8333240 | Roddy et al. | Dec 2012 | B2 |
8342242 | Roddy et al. | Jan 2013 | B2 |
8360160 | Giroux et al. | Jan 2013 | B2 |
8394744 | Woytowich et al. | Mar 2013 | B2 |
8399387 | Roddy et al. | Mar 2013 | B2 |
8403045 | Brenneis | Mar 2013 | B2 |
8434553 | Brenneis et al. | May 2013 | B2 |
8440596 | Brenneis et al. | May 2013 | B2 |
8470275 | Constantz et al. | Jun 2013 | B2 |
8486868 | Brenneis et al. | Jul 2013 | B2 |
8486869 | Brenneis et al. | Jul 2013 | B2 |
8505629 | Benkley et al. | Aug 2013 | B2 |
8505630 | Chatterji et al. | Aug 2013 | B2 |
8522873 | Benkley | Sep 2013 | B2 |
8540025 | Reddy et al. | Sep 2013 | B2 |
8544543 | Chatterji et al. | Oct 2013 | B2 |
8551923 | Benkley et al. | Oct 2013 | B1 |
8554543 | Cherepanov et al. | Oct 2013 | B2 |
8555967 | Chatterji et al. | Oct 2013 | B2 |
8586508 | Reddy et al. | Nov 2013 | B2 |
8586512 | Roddy et al. | Nov 2013 | B2 |
8598093 | Roddy et al. | Dec 2013 | B2 |
8603951 | Perez | Dec 2013 | B2 |
8609595 | Morgan | Dec 2013 | B2 |
8672028 | Karcher et al. | Mar 2014 | B2 |
8691737 | Chatterji et al. | Apr 2014 | B2 |
20020117090 | Ku | Aug 2002 | A1 |
20030116887 | Scott | Jun 2003 | A1 |
20040149431 | Wylie et al. | Aug 2004 | A1 |
20040187740 | Timmons | Sep 2004 | A1 |
20060166834 | Roddy | Jul 2006 | A1 |
20070056479 | Gray | Mar 2007 | A1 |
20070056732 | Roddy et al. | Mar 2007 | A1 |
20070137528 | Le Roy-Delage et al. | Jun 2007 | A1 |
20080169130 | Norman | Jul 2008 | A1 |
20080229979 | Lewis | Sep 2008 | A1 |
20090124522 | Roddy et al. | May 2009 | A1 |
20100044057 | Dealy et al. | Feb 2010 | A1 |
20100196104 | Constantz et al. | Aug 2010 | A1 |
20100258035 | Constantz et al. | Oct 2010 | A1 |
20100294496 | Woytowich et al. | Nov 2010 | A1 |
20110000400 | Roddy | Jan 2011 | A1 |
20120145387 | Pyatina et al. | Jun 2012 | A1 |
20120152539 | Karcher | Jun 2012 | A1 |
20120227631 | Roddy | Sep 2012 | A1 |
20120285682 | Santra et al. | Nov 2012 | A1 |
20120318506 | Benkley et al. | Dec 2012 | A1 |
20120325476 | Brenneis et al. | Dec 2012 | A1 |
20120328377 | Brenneis et al. | Dec 2012 | A1 |
20130008352 | Roddy et al. | Jan 2013 | A1 |
20130118752 | Hannegan et al. | May 2013 | A1 |
20130126159 | Bryan et al. | May 2013 | A1 |
20130153214 | Roddy et al. | Jun 2013 | A1 |
20130157903 | Benkley et al. | Jun 2013 | A1 |
20130210685 | Chatterji et al. | Aug 2013 | A1 |
20130213643 | Chatterji et al. | Aug 2013 | A1 |
20140048266 | Morgan et al. | Feb 2014 | A1 |
20140060389 | Chatterji et al. | Mar 2014 | A1 |
20140076204 | Brenneis et al. | Mar 2014 | A1 |
Number | Date | Country |
---|---|---|
2064682 | Apr 1992 | CA |
2336077 | Jan 2000 | CA |
2153372 | Jan 2006 | CA |
2736148 | May 2012 | CA |
0752048 | Jan 1997 | EP |
0814067 | Dec 1997 | EP |
1092693 | Apr 2001 | EP |
1236701 | Sep 2002 | EP |
1394137 | Jul 2003 | EP |
1348831 | Oct 2003 | EP |
1900703 | Mar 2008 | EP |
2075303 | Jul 2009 | EP |
1853680 | Apr 2010 | EP |
1769132 | Apr 2011 | EP |
1469954 | Apr 1997 | GB |
2455446 | Jun 2009 | GB |
WO 8301443 | Sep 1982 | WO |
WO 9321122 | Oct 1993 | WO |
WO 9721637 | Jun 1997 | WO |
WO 9854108 | Dec 1998 | WO |
WO 0063134 | Jan 2000 | WO |
WO 03031364 | Apr 2003 | WO |
WO 2004101951 | Nov 2004 | WO |
WO 2004101952 | Nov 2004 | WO |
WO 2005047212 | May 2005 | WO |
WO 2005061846 | Jul 2005 | WO |
WO 2006032841 | Mar 2006 | WO |
WO 2007028952 | Mar 2007 | WO |
WO 2007041841 | Apr 2007 | WO |
WO 2007048999 | May 2007 | WO |
WO 2007128945 | Nov 2007 | WO |
WO 2009071962 | Dec 2007 | WO |
WO 2006074946 | Jun 2009 | WO |
WO 2009138747 | Nov 2009 | WO |
WO 2010086592 | Aug 2010 | WO |
WO 2011051664 | May 2011 | WO |
WO 2012001343 | Jan 2012 | WO |
Entry |
---|
Hall, “Bridging Effectiveness of Perlite for Light Weight Cements and Lost Circulation”, Petroleum Branch, AIME, Paper No. 141-G, Oct. 1951. |
Saunders, “Trend in Use of Low-weight Cement Slurries”, Abstract, Mar. 1952. |
Murphy,“A Critique of Filler Cements”, Journal of Petroleum Technology, Aug. 1967. |
Sugama, “Carbonation of Hydrothermally Treated Phosphate-Bonded Calcium Aluminate Cements”, pp. 1-9, 1973. |
Herndon, “Setting Downhole Plugs: A State-of-the-Art”, Petroleum Engineer International, Apr. 1978. |
Morgan, R.G., Suter, D.A., and Sweat, V.A., “Mathematical Analysis of a Simple Back Extrusion Rheometer,” ASAE Paper No. 79/6001, Jun. 24, 1979. |
“API Specification for Materials and Testing for Well Cements”, API Spec. 10, 5th ed., pp. 7, 19-21, Jul. 1, 1980. |
The Professional Standard of the People's Republic of China, “Rotary Kiln Dust Added to Cement,” ZB Q 12001-84, issued by State Bureau of Building Material Industry, Oct. 25, 1984. |
Sersale, “Portland-Zeolite-Cement for Minimizing Alkali-Aggregate Expansion”, 1987. |
Smith, “Cementing” Society of Professional Engineers, pp. 14, 38, 1987. |
Nelson, “Well Cementing”, 1990. |
Smith, “Cementing” Society of Petroleum Engineers, p. 38, 1990. |
“Appendix A”, API RP 13B-2, 2d ed.; pp. 6-8, Dec. 1, 1991. |
Sugama, “Carbonation of Hydrothermally Treated Phosphate Bonded Calcium Aluminate Cements,” pp, 1-10, 1992. |
Vinson, “Acid Removable Cement System Helps Lost Circulation in Productive Zones”, IADC/SPE 23929, Feb. 18, 1992. |
Marfil, “Zeolite Crystallization in Portland Cement Concrete Due to Alkali-Aggregate Reaction”, 1993. |
Atkins, “Zeolite P in Cements”, “Its Potential for Immobilizing Toxic and Radioactive Waste Species”, 1995. |
Janotka, “The Properties of Mortar Using Blends With Portland Cement Clinker, Zeolite Tuff and Gypsum”, 1995. |
“Manufacture of supplementary cementitious materials from cement kiln dust”, Mishulovich et al., World Cement Research and Development, p. 116-120, Mar. 1996. |
Sugama, “Hot Alkali Carbonation of Sodium Metaphosphate Modified Fly Ash/Calcium Aluminate Blend Hydrothermal Cements”, pp. 1661-1672, Sep. 11, 1996. |
Rogers, “Designing a Remedial Acid Treatment for Gulf of Mexico Deepwater Turbidite Sands Containing Zeolite Cement”, 1996. |
Janotka, “Effect of Bentonite and Zeolite on Durability of Cement Suspension Under Sulfate Attack”, 1998. |
Naiqian, “Study on the Suppression Effect of Natural Zeolite on Expansion of Concrete Due to Alkali-Aggregate Reaction”, 1998. |
Chan, Comparative Study of the Initial Surface Absorption and Chloride Diffusion of High Performance Zeolite Silica Fume and PFA concretes, 1999. |
Poon, “A Study of the Hydration of Natural Zeolite Blended Cement Pastes”, 1999. |
Ding, “Extreme Vertices Design of Concrete With Combined Mineral Admixtures”, 1999. |
Feng, “Zeolite Ceramiste Cellular Concrete”, 2000. |
Bartlet-Gouedard, “A Non-Conventional Way of Developing Cement Slurry for Geothermal Wells”, 2001. |
TXI Material Safety Data Sheet for Pressur-Seal, Oct. 2003. |
“Kiln Dusts”, Apr. 14, 2005. |
“Beneficial use of Solid Waste in Maine”, Apr. 14, 2005. |
“Standards for the Management of Cement Kiln Dust Waste”, Apr. 14, 2005. |
“Use of Cement Kiln Dust for the Stabilization of Soils”, R. L. Parsons, et al., Apr. 14, 2005. |
“Alkali-activated binders by use of industrial by-products”, Buchwald et al., Cement and concrete Research 35, p. 968-973, 2005. |
Answer 3 of 24 Chemical Abstracts on STN “Effect of cement kiln dust substitution on chemical and physical properties and compressive strength of Portland and slag cements”, Adb El-aleem et al. (abstract only), 2005. |
Adaska and Taubert, “Beneficial Uses of Cement Kiln Dust”, 2008 IEEE/PCA 50th Cement Industry technical Conference, Miami, Fl, May 19-22, 2008, pp. 1-19, 2008. |
“Fly Ash Resource Center-Pozzolan,” available at http://www.rmajko.com/pozzolan.htm, Apr. 20, 2009. |
Suyan, “An innovative Material for Severe Lost Circulation Control in Depleted Formations” SPE/IADC 125693, Oct. 2009. |
The Schundler Company, “Perlite as an Ultra Fine Filler”, Schundler Product Guide, http://www.schundler.com/filler.htm, 2010. |
IP.com Electronic Publication, “Use of Cement Kiln Dust (CKD) in Low Temperature Cementing to Reduce Transition Times”, Sep. 25, 2013. |
HES Brochure “SCR-100 Cement Retarder a Valuable Time Saver”, 1994. |
HES Brochure “Halad-344 Fluid Loss Additive”, 1998. |
HES Brochure “HR-5 Cement Additive”, 1998. |
HES Brochure “AQF-2 Foaming Agent”, 1999. |
HES Brochure “ThermaLock™ Cement for Corrosive CO2 Environments”, 1999. |
HES Brochure “Halad-413 Fluid Loss Additive”, 1999. |
HES Brochure “Howco Suds Surfactant”, 1999. |
HES Brochure “HR-12 Cement Retarder”, 1999. |
HES Brochure “HR-15 Cement Retarder”, 1999. |
HES Brochure “HR-25 Cement Retarder”, 1999. |
HES Brochure “HR-4 Cement Retarder”, 1999. |
HES Brochure “HR-7 Cement Retarder”, 1999. |
HES Brochure “Pozmix a Cement Additive”, 1999. |
HES Brochure “Pozmix Cement and Pozmix 140”, 1999. |
HES Brochure “SCR-100T™ Cement Retarder”, 1999. |
HES Brochure “SCR-500L High Temp Retarder”, 2000. |
HES Brochure “Halad-23 Fluid Loss Additive”, 2000. |
HES Brochure “Thermatek Service”, May 2005. |
HES Brochure “Tuned Spacer™ III”, Apr. 2007. |
HES Brochure “Cal-Seal 60™ Cement Accelerator”, Aug. 2007. |
HES Brochure “Cementing-Perlite Cement Additive”, Aug. 2007. |
HES Brochure “Econolite™ Additive for cement Slurries”, Aug. 2007. |
HES Brochure “Silicalite™”, Aug. 2007. |
HES Brochure “SSA-1™ Strenght-Stabilizing Agent”, Aug. 2007. |
HES Brochure “SSA-2™ Coarse Silica Flour”, Aug. 2007. |
HES Brochure “WG-17 LXP™ Free-Water Control Agent”, Dec. 2007. |
HES Brochure “HR®-601 Cement Retarder”, Jan. 2008. |
HES Brochure “Thermatek® RSP Rapid Set Plug Service”, Mar. 2008. |
HES Product Data Sheet “Baroid®”, Mar. 25, 2010. |
HES Brochure “Enhancer 923™ Cement Agent”, Jun. 2010. |
HES Brochure “Enhancer 923™ Agent-Successes from the Field”, Jun. 2010. |
HES Brochure “Latex 3000™ Cement Additive”, Jun. 2010. |
HES Brochure “Foamer 760™ foamer/Stabilizer”, Aug. 2010. |
HES Brochure “Tuned® Spacer IV”, Aug. 2010. |
HES Brochure “Tuned® Spacer V”, Dec. 2010. |
HES Brochure “D-Air 5000™ Defoamer”, Aug. 2011. |
HES Brochure “SA-1015™ Suspending Agent”, Mar. 2012. |
HES Brochure “WellLife® III Cementing Service”, Jan. 2012. |
HES Brochure “TergoVis1 efficiency fluid”, Apr. 2013. |
“3M Scotchlite, Glass Bubbles Floated Product Series Product Information”, 1999. |
BASF Technical Bulletin “MetaMax® PA”, Aug. 2007. |
Hess Pumice Products Inc., Fact Sheet for “DS-200”, “DS-325”, and “Ultrafine Grout”, Aug. 2007. |
LAFARGE MSDS “Cement Kiln Dust”, Mar. 3, 2005. |
LAFARGE MSDS “LaFarge Blended Cement (cement)”, Mar. 3, 2005. |
LAFARGE brochure “TerraCemTM™”, Aug. 2006. |
Office Action from U.S. Appl. No. 11/223,671, Dec. 15, 2005. |
Office Action from U.S. Appl. No. 11/271,431, Mar. 6, 2006. |
Office Action from U.S. Appl. No. 11/223,671, Mar. 31, 2006. |
Office Action from U.S. Appl. No. 11/271,431, May 17, 2006. |
Office Action from U.S. Appl. No. 11/271,431 (Advisory Action), Jul. 11, 2006. |
Office Action from U.S. Appl. No. 11/416,563, Jul. 21, 2006. |
Office Action from U.S. Appl. No. 11/403,032, Jul. 24, 2006. |
Office Action from U.S. Appl. No. 11/271,431, Aug. 15, 2006. |
Office Action from U.S. Appl. No. 11/440,627, Aug. 21, 2006. |
Office Action from U.S. Appl. No. 11/402,741, Oct. 19, 2006. |
Office Action from U.S. Appl. No. 11/484,951, Oct. 26, 2006. |
Office Action from U.S. Appl. No. 11/484,951, Dec. 21, 2006. |
Office Action from U.S. Appl. No. 11/223,703, Jan. 17, 2007. |
Office Action from U.S. Appl. No. 11/402,741, Feb. 2, 2007. |
Office Action from U.S. Appl. No. 11/223,485, Feb. 28, 2007. |
Office Action from U.S. Appl. No. 11/223,669, Feb. 28, 2007. |
Office Action from U.S. Appl. No. 11/271,690, Mar. 13, 2007. |
Office Action from U.S. Appl. No. 11/402,741, Mar. 22, 2007. |
Office Action from U.S. Appl. No. 11/223,703, Apr. 25, 2007. |
Office Action from U.S. Appl. No. 11/402,741, May 29, 2007. |
Office Action from U.S. Appl. No. 11/223,669, Jun. 18, 2007. |
Office Action from U.S. Appl. No. 11/257,261, Aug. 10, 2007. |
Office Action from U.S. Appl. No. 11/402,741, Sep. 6, 2007. |
Office Action from U.S. Appl. No. 11/223,669, Oct. 9, 2007. |
Office Action from U.S. Appl. No. 11/223,750, Oct. 16, 2007. |
Office Action from U.S. Appl. No. 11/402,741, Oct. 24, 2007. |
Office Action from U.S. Appl. No. 11/223,669, Jan. 29, 2008. |
Office Action from U.S. Appl. No. 11/223,669, Apr. 8, 2008. |
Office Action from U.S. Appl. No. 12/263,800, May 1, 2009. |
Office Action from U.S. Appl. No. 12/283,398, Jul. 15, 2009. |
Office Action from U.S. Appl. No. 12/263,800, Jul. 28, 2009. |
Office Action from U.S. Appl. No. 12/420,630, Aug. 3, 2009. |
Office Action from U.S. Appl. No. 12/349,676, Nov. 4, 2009. |
Office Action from U.S. Appl. No. 12/606,381, Mar. 23, 2010. |
Office Action from U.S. Appl. No. 12/609,993, Apr. 9, 2010. |
Office Action from U.S. Appl. No. 12/609,993, Jun. 15, 2010. |
Office Action from U.S. Appl. No. 12/558,097, Jun. 30, 2010. |
Notice of Allowance from U.S. Appl. No. 12/609,993, Jul. 26, 2010. |
Office Action from U.S. Appl. No. 12/558,097, Sep. 3, 2010. |
Office Action from U.S. Appl. No. 12/833,189, Oct. 1, 2010. |
Office Action from U.S. Appl. No. 12/844,612, Oct. 1, 2010. |
Office Action from U.S. Appl. No. 12/364,998, Jan. 14, 2011. |
Office Action from U.S. Appl. No. 12/844,612, Jan. 28, 2011. |
Notice of Allowance from U.S. Appl. No. 12/544,915, Aug. 1, 2011. |
Office Action from U.S. Appl. No. 12/844,612, Sep. 6, 2011. |
Office Action from U.S. Appl. No. 12/264,010, Oct. 31, 2011. |
Final Office Action from U.S. Appl. No. 12/844,612, Dec. 23, 2011. |
Final Office Action from U.S. Appl. No. 12/264,010, Apr. 10, 2012. |
Office Action from U.S. Appl. No. 12/844,612, Apr. 11, 2012. |
Office Action from U.S. Appl. No. 13/399,913, May 15, 2012. |
Office Action from U.S. Appl. No. 13/447,560, May 31, 2012. |
Office Action from U.S. Appl. No. 12/821,412, Jun. 5, 2012. |
Office Action from U.S. Appl. No. 12/825,004, Jun. 14, 2012. |
Notice of Allowance from U.S. Appl. No. 13/447,560, Jun. 21, 2012. |
Office action from U.S. Appl. No. 13/479,476, Jul. 2, 2012. |
Office action from U.S. Appl. No. 12/975,196, Jul. 3, 2012. |
Final Office Action from U.S. Appl. No. 12/844,612, Jul. 30, 2012. |
Notice of Allowance from U.S. Appl. No. 13/399,913, Aug. 23, 2012. |
Notice of Allowance from U.S. Appl. No. 13/535,258, Sep. 7, 2012. |
Notice of Allowance from U.S. Appl. No. 12/825,004, Sep. 20, 2012. |
Office Action from U.S. Appl. No. 13/477,777, Oct. 15, 2012. |
Office Action from U.S. Appl. No. 13/560,406, Oct. 17, 2012. |
Notice of Allowance from U.S. Appl. No. 12/844,612, Oct. 18, 2012. |
Office Action from U.S. Appl. No. 13/555,624, Oct. 19, 2012. |
Final Office Action from U.S. Appl. No. 12/975,196, Oct. 23, 2012. |
Office Action from U.S. Appl. No. 13/431,701, Nov. 9, 2012. |
Office Action from U.S. Appl. No. 13/620,163, Nov. 9, 2012. |
Office Action from U.S. Appl. No. 13/606,098, Dec. 13, 2012. |
Office Action from U.S. Appl. No. 13/669,149, Dec. 19, 2012. |
Office Action from U.S. Appl. No. 13/620,013, Feb. 26, 2013. |
Office Action from U.S. Appl. No. 13/725,833, Apr. 10, 2013. |
Notice of Allowance from U.S. Appl. No. 13/669,149, May. 13, 2013. |
Notice of Allowance form U.S. Appl. No. 13/535,145, May 24, 2013. |
Office Action from U.S. Appl. No. 13/620,013, May 28, 2013. |
Notice of Allowance from U.S. Appl. No. 12/895,436, May 28, 2013. |
Final Office Action from U.S. Appl. No. 13/477,777, May 29, 2013. |
Notice of Allowance from U.S. Appl. No. 13/560,406, May 29, 2013. |
Office Action from U.S. Appl. No. 13/851,925, Jun. 6, 2013. |
Office Action from U.S. Appl. No. 13/889,398, Jun. 20, 2013. |
Office Action from U.S. Appl. No. 13/851,391, Jul. 3, 2013. |
Office Action from U.S. Appl. No. 13/872,063, Jul. 12, 2013. |
Office Action from U.S. Appl. No. 13/767,710, Jul. 19, 2013. |
Notice of Allowance from U.S. Appl. No. 13/851,391, Jul. 31, 2013. |
Notice of Allowance from U.S. Appl. No. 13/889,398, Aug. 20, 2013. |
Final Office Action from U.S. Appl. No. 13/477,777, Sep. 20, 2013. |
Office Action from U.S. Appl. No. 13/767,710, Sep. 20, 2013. |
Final Office Action from U.S. Appl. No. 13/851,925, Sep. 20, 2013. |
Office Action from U.S. Appl. No. 13/180,238, Sep. 25, 2013. |
Final Office Action from U.S. Appl. No. 13/620,013, Oct. 2, 2013. |
Notice of Allowance from U.S. Appl. No. 13/662,111, Oct. 21, 2013. |
Office Action form U.S. Appl. No. 13/955,516, Dec. 19, 2013. |
Notice of Allowance from U.S. Appl. No. 13/180,238, Jan. 22, 2014. |
Notice of Allowance from U.S. Appl. No. 13/851,925, Jan. 24, 2014. |
Office Action from U.S. Appl. No. 13/851,475, Jan. 24, 2014. |
Office Action from U.S. Appl. No. 13/620,013, Jan. 30, 2014. |
Office Action from U.S. Appl. No. 14/079,421, Jan. 30, 2014. |
Office Action from U.S. Appl. No. 14/091,332, Jun. 19, 2014. |
U.S. Appl. No. 13/622,821, first named inventor Brenneis et. al., filed Sep. 19, 2012. |
USPTO Office Action for U.S. Appl. No. 14/091,332 dated Oct. 27, 2014. |
Number | Date | Country | |
---|---|---|---|
20140326446 A1 | Nov 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14091332 | Nov 2013 | US |
Child | 14312253 | US | |
Parent | 13725833 | Dec 2012 | US |
Child | 13851925 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13851925 | Mar 2013 | US |
Child | 14091332 | US | |
Parent | 13535145 | Jun 2012 | US |
Child | 13725833 | US | |
Parent | 12895436 | Sep 2010 | US |
Child | 13535145 | US | |
Parent | 12264010 | Nov 2008 | US |
Child | 12895436 | US | |
Parent | 11223669 | Sep 2005 | US |
Child | 12264010 | US |